{"entity":{"type":"insider","cik":"0001959547","url":"/insider/0001959547","json_url":"/insider/0001959547.json","name":"Myers Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":2,"first":"2024-09-05","last":"2024-12-27","span_basis":"filed_date"},"name_variants":[{"name":"Myers Michael","source":"filing","n_filings":2,"first_seen":"2024-09-05","last_seen":"2024-12-27"}],"transactions":[{"id":2876289,"accession":"0001104659-24-132188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-132188","line_url":"/filing/0001104659-24-132188#line-1","is_derivative":false,"issuer_cik":"0001671502","issuer_name":"Quoin Pharmaceuticals, Ltd.","issuer_ticker":"QNRX","issuer_name_source":null,"issuer_url":"/issuer/0001671502","owner_cik":"0001959547","owner_name":"Myers Michael","owner_display_name":"Myers Michael","owner_url":"/insider/0001959547","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":555556.0,"shares_display":"555,556","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":250000.2,"total_display":"250,000.20","total_whole":"250,000","shares_owned_after":602808.0,"shares_owned_after_display":"602,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-27","scope":"insider"},{"id":2076398,"accession":"0001104659-24-097254","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-097254","line_url":"/filing/0001104659-24-097254","is_derivative":false,"issuer_cik":"0001671502","issuer_name":"Quoin Pharmaceuticals, Ltd.","issuer_ticker":"QNRX","issuer_name_source":null,"issuer_url":"/issuer/0001671502","owner_cik":"0001959547","owner_name":"Myers Michael","owner_display_name":"Myers Michael","owner_url":"/insider/0001959547","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37094.0,"shares_display":"37,094","price_per_share":0.7661859168598695,"price_display":"0.77","price_state":"stated","total_value":28420.9004,"total_display":"28,420.90","total_whole":"28,421","shares_owned_after":23680.0,"shares_owned_after_display":"23,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-04","filed_date":"2024-09-05","scope":"insider","n_lines":3},{"id":2076392,"accession":"0001104659-24-097254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-097254","line_url":"/filing/0001104659-24-097254#line-1","is_derivative":false,"issuer_cik":"0001671502","issuer_name":"Quoin Pharmaceuticals, Ltd.","issuer_ticker":"QNRX","issuer_name_source":null,"issuer_url":"/issuer/0001671502","owner_cik":"0001959547","owner_name":"Myers Michael","owner_display_name":"Myers Michael","owner_url":"/insider/0001959547","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":0.619,"price_display":"0.62","price_state":"stated","total_value":495.2,"total_display":"495.20","total_whole":"495","shares_owned_after":10158.0,"shares_owned_after_display":"10,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001671502","name":"Quoin Pharmaceuticals, Ltd.","url":"/issuer/0001671502","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2024-09-05","last_seen":"2024-12-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001959547","retrieved_at":"2026-08-25T19:55:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}